Clinical and Histological Analysis of Human Gingival Phenotypes

Healthy Clinical Trial

Official title:

Clinical, Histological and Immunohistochemical Characterization of Human Gingival Phenotypes

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05923671
• Other study ID #: 1399
• Status: Completed
• Start date: March 5, 2020
• Est. completion date: December 1, 2022

Study information

• Verified date: June 2023
• Source: Aristotle University Of Thessaloniki
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this observational study is to compare the composition of the human gingiva in different gingival phenotypes. The main questions to answer are: - Is there any difference in the cellular composition of the gingiva between thin and thick gingival phenotype? - Is there any difference in the molecular composition of the gingiva between thin and thick gingival phenotype? The participants were divided in two groups (thin and thick phenotype) and a biopsy of healthy gingiva was obtained from each one them. The biopsies were analyzed histologically and the collected data will be analyzed statistically in order to identify possible differences between the gingival phenotypes.

Description:

Healthy volunteers were assigned in one of two groups: - Group 1: Thin gingiva, when the free gingiva was evaluated as transparent, after the insertion of a periodontal probe (Hu-Friedy XP-23/QW, Hu-Friedy,Chicago,IL,USA) in the middle of the facial dentogingival sulcus of a maxillary central incisor - Group 2: Thick gingiva: when the free gingiva was evaluated as non-transparent, using the same methodology. A full thickness sample of the oral mucosa of each one of the participants was collected under local anaesthesia. The sample had a rectangular shape, with a length of 4 millimeters and a width of 1 millimeter. It had a vertical orientation and it was expanding at the both sides of the mucogingival junction. The oral mucosa samples were processed for histological and immunohistochemical analysis. Staining with haematoxylin-eosin was performed in order to describe the tissue histologically and also calculate the total number of the cells it contained. Immunohistochemical staining with anti-Vimentin,anti-Cluster of Differentiation 68, anti-Ki-67 and anti-Smooth Muscle Actin antibodies was applied for the calculation of the numbers of fibroblasts, macrophages, Ki-67-positive cells and Smooth muscle actin positive cells respectively. Immunohistochemical staining was also performed in order to determine the levels of expression of Collagen I, Collagen V, Elastin and Hyaluronic acid. Whole slide images of the specimens were acquired with the use of the NanoZoomer 2.0HT (Hamamatsu Pho-tonics K.K., Hamamatsu, Japan). Cell counting will be performed automatically using an image analysis software (QuPath 3.0). The levels of molecular expression will be assessed with the use of the same software and will be expressed as a percentage of the area of the connective tissue that is occupied by the investigated molecules.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 45
• Est. completion date: December 1, 2022
• Est. primary completion date: December 1, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Healthy adults

Exclusion Criteria:

• Attachment loss or Probing depths greater than 2 millimeters at the maxillary central incisors
• Altered passive eruption of the maxillary incisors
• Previous surgery or orthodontic treatment in the anterior maxilla
• Medical conditions or medication affecting soft tissue metabolism
• Tooth crowding or abnormal angulation or abrasion of the maxillary incisors
• Restorations at the buccal surface of the maxillary central incisors
• Smoking
• Pregnancy or lactation

Related Conditions & MeSH terms

• Healthy

Intervention

Diagnostic Test:
• Histological analysis
Histological staining of gingival biopsies with haematoxylin-eosin.
• Immunohistochemical analysis
Immunohistochemical staining of gingival biopsies using anti-Vimentin, anti-Collagen I, anti-Collagen V, anti-Elastin, anti-Hyaluronic acid, anti-Smooth muscle actin, anti-Cluster of Differentiation 68 and anti-ki67 antibodies.

Locations

Country	Name	City	State
Greece	Aristotle University of Thessaloniki	Thessaloniki	Macedonia

Sponsors (2)

Lead Sponsor	Collaborator
Aristotle University Of Thessaloniki	Umeå University

Country where clinical trial is conducted

Greece, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Keratinized tissue width	The length (millimeters) of the line that connects the mucogingival junction and the gingival margin, at the middle of the facial surface of the maxillary central incisor	Baseline
Other	Gingival thickness	The thickness (millimeters) of the gingiva, measured with an ultrasonic biometer (PIROP Biometric scanner, ECHO-SON S.A., Poland) at the middle of the line that connects the mucogingival junction and the gingival margin, at the middle of the facial surface of the maxillary central incisor	Baseline
Primary	Cell density	The number of all types of cells per square millimeter of the connective tissue	Baseline
Secondary	Fibroblast Density	The number of fibroblasts per square millimeter of the connective tissue	Baseline
Secondary	Macrophage Density	The number of macrophages per square millimeter of the connective tissue	Baseline
Secondary	Density of Ki-67-positive cells	The number of Ki-67-positive cells per square millimeter of the connective tissue	Baseline
Secondary	Density of Smooth Muscle Actin positive cells	The number of Smooth Muscle Actin positive cells per square millimeter of the connective tissue	Baseline
Secondary	Collagen I area ratio	The percentage of the area of the connective tissue which is occupied by Collagen I	Baseline
Secondary	Collagen V area ratio	The percentage of the area of the connective tissue which is occupied by Collagen V	Baseline
Secondary	Elastin area ratio	The percentage of the area of the connective tissue which is occupied by Elastin	Baseline
Secondary	Hyaluronic acid area ratio	The percentage of the area of the connective tissue which is occupied by Hyaluronic acid	Baseline